Acrivon Therapeutics, Inc.

7.65 USD
+0.40 (+5.52%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Acrivon Therapeutics, Inc. stock is down -10.63% since 30 days ago. The next earnings date is Aug 9, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 1 June’s closed higher than May.

About Acrivon Therapeutics, Inc.

We are a clinical stage biopharmaceutical company developing precision oncology medicines that we match to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing our proprietary proteomics-based patient responder identification platform. We were incorporated under the laws of the State of Delaware in March 2018. Our principal executive offices are located at 480 Arsenal Way, Suite 100, Watertown, Massachusetts.